Evidence map›Paper›PMID 40896384›Full record

ArticleHealth affairs scholar2025

Effectiveness of Washington State's hub and spoke model to improve opioid use disorder outcomes.

Sharon Reif, Maureen T Stewart, Shay M Daily, Lee Panas, Grant A Ritter, Mary F Brolin, Margaret T Lee, Jennifer J Wicks

Abstract read
In one paragraph

Article in Health affairs scholar, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sharon ReifInstitute for Behavioral Health, Schneider Institutes for Health Policy and Research, Heller School for Social Policy and Management, Brandeis University, 415 South Street, Waltham, MA 02453, United States.ORCID https://orcid.org/0000-0002-9234-5641
Maureen T StewartInstitute for Behavioral Health, Schneider Institutes for Health Policy and Research, Heller School for Social Policy and Management, Brandeis University, 415 South Street, Waltham, MA 02453, United States.ORCID https://orcid.org/0000-0002-5470-0307
Shay M DailyInstitute for Behavioral Health, Schneider Institutes for Health Policy and Research, Heller School for Social Policy and Management, Brandeis University, 415 South Street, Waltham, MA 02453, United States.ORCID https://orcid.org/0000-0003-0455-6762
Lee PanasInstitute for Behavioral Health, Schneider Institutes for Health Policy and Research, Heller School for Social Policy and Management, Brandeis University, 415 South Street, Waltham, MA 02453, United States.ORCID https://orcid.org/0009-0008-4959-9567
Grant A RitterInstitute for Behavioral Health, Schneider Institutes for Health Policy and Research, Heller School for Social Policy and Management, Brandeis University, 415 South Street, Waltham, MA 02453, United States.ORCID https://orcid.org/0000-0002-1009-4878
Mary F BrolinInstitute for Behavioral Health, Schneider Institutes for Health Policy and Research, Heller School for Social Policy and Management, Brandeis University, 415 South Street, Waltham, MA 02453, United States.ORCID https://orcid.org/0000-0002-0286-4860
Margaret T LeeInstitute for Behavioral Health, Schneider Institutes for Health Policy and Research, Heller School for Social Policy and Management, Brandeis University, 415 South Street, Waltham, MA 02453, United States.
Jennifer J WicksInstitute for Behavioral Health, Schneider Institutes for Health Policy and Research, Heller School for Social Policy and Management, Brandeis University, 415 South Street, Waltham, MA 02453, United States.ORCID https://orcid.org/0000-0003-0887-8611

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Innovative strategies remain necessary to increase utilization of medications for opioid use disorder (MOUD), an effective approach to reduce overdoses and deaths. The hub and spoke (HS) model is increasingly used to improve MOUD treatment, yet the impact is relatively unknown. We assessed the effectiveness of Washington State's hub and spoke (WA-HS) model on 6-month outcomes of MOUD continuity and health care utilization. Methods: We analyzed 25 368 adult Medicaid beneficiaries with new MOUD episodes in 2016-2019, comparing HS and non-HS cohorts in the 6 months after starting MOUD. Results: Across both cohorts, 26% stayed on MOUD for 6 months, and within 6 months of MOUD initiation, 42% had an emergency department (ED) visit, 14% had any hospitalization, and 13% entered intensive substance use treatment. No significant differences were found between cohorts for all outcomes. Conclusion: Our null findings likely reflect the complexity of the OUD crisis, the many needs of people with OUD that require flexible approaches at the individual and systems levels, and the WA-HS focus on MOUD initiation. Findings highlight the need to ensure HS models incorporate strategies to address MOUD continuity to drive long-term recovery for people with OUD.

Indexed as

addictionbuprenorphineeffectivenessmedicationmethadoneMOUDopioid use disorderretentiontreatment

Identifiers

PMID40896384
PMCPMC12392894

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.